Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases, special treatments, and others; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood products, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
तुलना करने के लिए मीट्रिक्स | BLAU3 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधBLAU3पीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 13.0x | −4.1x | −0.6x | |
PEG अनुपात | −0.32 | −0.26 | 0.00 | |
क़ीमत/बुक | 1.2x | 3.6x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 1.4x | 7.3x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 29.8% | 256.7% | 44.6% | |
उचित मूल्य अपसाइड | अनलॉक करें | 14.1% | 7.3% | अनलॉक करें |